Treatment of diffuse cutaneous leishmaniasis with miltefosine: a case report.
A 31-year-old man who has suffered since age 3 from diffuse cutaneous leishmaniasis (DCL), a disease with profound physical and psychosocial repercussions and no effective treatment at present, was treated with miltefosine. The patient was treated for 120 days, 100 mg/day for 1 week, then 150 mg/day subsequently. Lesions were free of parasites at 43 days, and no signs of infiltration were present at day 76. No adverse side effects were observed. The dramatic clinical effect of miltefosine in this patient appears to fully justify further evaluation of this experimental therapy in DCL.